Revised Geneva Score Calculator
For Clinical Probability of Pulmonary Embolism (PE)
The Revised Geneva Score is a clinical prediction rule that estimates the pre-test probability of Pulmonary Embolism (PE) based on objective criteria.
Revised Geneva Score Result
Clinical Probability & Interpretation
Recommended Diagnostic Approach:
About the Revised Geneva Score
The Revised Geneva Score is a validated clinical prediction rule that uses objective criteria to estimate the pre-test probability of pulmonary embolism.
Scoring System:
| Clinical Factor | Points |
|---|---|
| Age > 65 years | 1 |
| Previous DVT or PE | 3 |
| Surgery or fracture within 1 month | 2 |
| Active malignancy | 2 |
| Unilateral leg pain | 3 |
| Hemoptysis | 2 |
| Heart rate 75-94 bpm | 3 |
| Heart rate ≥ 95 bpm | 5 |
| Pain on palpation + unilateral edema | 4 |
Clinical Decision Algorithm
Low Probability (0-3 points): Consider D-dimer testing. If negative, PE can be ruled out. If positive, proceed to CTPA.
Intermediate Probability (4-10 points): Proceed directly to diagnostic imaging (CTPA).
High Probability (≥11 points): High likelihood of PE. Immediate diagnostic imaging (CTPA) is indicated.
The Revised Geneva Score is a standardized, validated method to estimate the clinical probability of a pulmonary embolism. It helps clinicians decide which patients with symptoms like chest pain or shortness of breath should undergo more advanced (and often more costly or invasive) testing, such as a CT Pulmonary Angiogram (CTPA) or V/Q scan.
Its main strength is that it relies entirely on objective clinical criteria, making it less susceptible to interpreter bias compared to some other scores.
Detailed Breakdown
1. Clinical Context and Purpose
When a patient presents with symptoms that could be a PE (e.g., pleuritic chest pain, dyspnea, syncope), the clinician is faced with a dilemma: ordering a CTPA on everyone is inefficient and exposes many patients to unnecessary radiation and contrast dye. The Revised Geneva Score helps triage these patients.
Its primary uses are:
- Stratifying Probability:Â Categorizing patients into “low,” “intermediate,” or “high” probability for PE.
- Guiding Diagnostic Workup:Â The score is used in combination with a D-dimer blood test to rule out PE safely without imaging.
- Standardizing Clinical Assessment:Â Providing an evidence-based framework for evaluating PE suspicion.
2. How the Score is Calculated
The score is calculated by adding points assigned to specific risk factors and clinical findings. There are no laboratory or imaging results required.
Here are the variables and their point assignments:
| Clinical Factor | Points |
|---|---|
| Risk Factors | |
| Age > 65 years | 1 |
| Previous DVT or PE | 3 |
| Surgery or fracture within 1 month | 2 |
| Active malignancy (solid or hematologic) | 2 |
| Symptoms | |
| Unilateral leg pain | 3 |
| Hemoptysis (coughing up blood) | 2 |
| Clinical Signs | |
| Heart rate 75–94 bpm | 3 |
| Heart rate ≥ 95 bpm | 5 |
| Pain on deep vein palpation and unilateral edema | 4 |
Total Score Range: 0 to 22
3. Interpretation of the Score
The total points determine the clinical probability of Pulmonary Embolism:
| Total Points | Clinical Probability | Pre-test Probability of PE |
|---|---|---|
| 0 – 3 | Low Probability | ~8% |
| 4 – 10 | Intermediate Probability | ~28% |
| ≥ 11 | High Probability | ~74% |
Clinical Application: The Diagnostic Algorithm
The real power of the score is in how it guides the next diagnostic steps, typically in conjunction with a D-dimer test:
- Low Probability Score (0-3 points):
- A negative D-dimer test reliably excludes PE. No further imaging is needed.
- A positive D-dimer test warrants moving to diagnostic imaging (CTPA).
- Intermediate/High Probability Score (≥4 points):
- D-dimer is less useful here because it’s often positive due to other reasons (age, cancer, inflammation).
- These patients should typically proceed directly to diagnostic imaging (CTPA).
Comparison with Other PE Prediction Scores
The main alternative to the Revised Geneva Score is the Wells’ Criteria for PE.
| Feature | Revised Geneva Score | Wells’ Criteria for PE |
|---|---|---|
| Basis | Purely objective (age, HR, specific signs) | Includes a subjective element (“PE is #1 diagnosis” or “an alternative diagnosis is less likely”) |
| Variables | 8 items | 7 items |
| Advantage | Highly reproducible between different clinicians | Excellent predictive value, widely validated |
| Disadvantage | May be slightly less specific than Wells’ | Subjective component can introduce variability |
Summary
The Revised Geneva Score is a crucial tool in the modern diagnostic workup for pulmonary embolism. By providing an objective assessment of clinical probability, it helps clinicians:
- Safely rule out PEÂ in low-risk patients using a simple D-dimer test, avoiding unnecessary radiation.
- Justify proceeding to imaging in intermediate and high-risk patients.
- Standardize the approach to a common and potentially lethal condition.
Disclaimer: This information is for educational purposes only. The diagnosis and management of pulmonary embolism is a complex medical process that must be directed by qualified healthcare professionals. Clinical judgment should always supersede any scoring system.
